World Sickle Cell Day 2023!
Sickle Cell has not only taken away everything I had but has also robbed me of my dignity. Strangely enough, Sickle Cell has also played a crucial role in shaping my success stories.
Pfizer announced today the results of its Phase 3 THRIVE-131 study evaluating inclacumab. While inclacumab was generally well tolerated, the study found that it did not meet its primary endpoint of significantly reducing the rate of vaso-occlusive crises (VOCs) in participants.
If you are living with Sickle Cell or are a caregiver, support is available:
📞 Call or text: 414-432-3555
📧 Email: info@alaafiaafrc.org
🌐 Visit: alaafiaafrc.org to learn more.
Through collaboration and the exchange of experiences, we harness the strength of connection. Every smile represents an opportunity to motivate and encourage one another.
#UnitedInPurpose
If you are living with Sickle Cell or are a caregiver, support is available:
📞 Call or text: 414-432-3555
📧 Email: info@alaafiaafrc.org
🌐 Visit: alaafiaafrc.org to learn more.
If you are living with Sickle Cell or are a caregiver, support is available:
📞 Call or text: 414-432-3555
📧 Email: info@alaafiaafrc.org
🌐 Visit: alaafiaafrc.org to learn more.
If you are living with Sickle Cell or are a caregiver, support is available:
📞 Call or text: 414-432-3555
📧 Email: info@alaafiaafrc.org
🌐 Visit: alaafiaafrc.org to learn more.